Daming Gao相关文献与解析，生知库 | 链接生命科学的每一步

Zhang, Ke; Zhou, Daming; Gao, Ningfei; Zhang, Jiahao; Tong, Zhongzhen; Zhao, Jibo; Liu, Peng; Wang, Xinhe; Lin, Xiaoyang; Xu, Haitao; Peng, Lian-Mao; Zhao, Weisheng

发表日期：2025

文献求助收藏

Pan-cancer proteogenomics expands the landscape of therapeutic targets

泛癌症蛋白质组学拓展了治疗靶点的范围

期刊:Cell

影响因子:45.5

doi:10.1016/j.cell.2024.05.039

Sara R Savage, Xinpei Yi, Jonathan T Lei, Bo Wen, Hongwei Zhao, Yuxing Liao, Eric J Jaehnig, Lauren K Somes, Paul W Shafer, Tobie D Lee, Zile Fu, Yongchao Dou, Zhiao Shi, Daming Gao, Valentina Hoyos, Qiang Gao, Bing Zhang

肿瘤

发表日期：2024

文献求助收藏

An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma

IL1RN 剪接产生的炎症检查点为 KRAS 突变型肝内胆管癌提供了治疗机会

期刊:Cancer Discovery

影响因子:29.7

doi:10.1158/2159-8290.CD-23-0282

Mao Zhang #, Yingying Huang #, Jiaomeng Pan #, Chen Sang #, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Wu, Guohe Song, Shuyi Ji, Fen Liu, Mengcheng Wang, Yuyan Zheng, Sirui Zhang, Zefeng Wang, Jianke Ren, Daming Gao, Jian Zhou, Jia Fan, Wu Wei, Jian Lin, Qiang Gao

Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma

基因组规模的 CRISPR 筛选确定了肝细胞癌中驱动仑伐替尼耐药性的 LAPTM5

期刊:Autophagy

影响因子:14.6

doi:10.1080/15548627.2022.2117893

Jiaomeng Pan, Mao Zhang, Liangqing Dong, Shuyi Ji, Juan Zhang, Shu Zhang, Youpei Lin, Xiaoying Wang, Zhenbin Ding, Shuangjian Qiu, Daming Gao, Jian Zhou, Jia Fan, Qiang Gao

CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs

CircRNF10通过重新激活GSC中的铁死亡防御机制，触发正反馈回路，促进胶质母细胞瘤的进展。

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-023-02816-9

Wang, Chengbin; Zhang, Minjie; Liu, Yingliang; Cui, Daming; Gao, Liang; Jiang, Yang

Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

肿瘤免疫微环境及NRF2与肺鳞状细胞癌PD-1阻断联合化疗临床疗效的关系

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2023.101302

Jianchun Duan, Yun Zhang, Ran Chen, Liang Liang, Yi Huo, Shun Lu, Jun Zhao, Chunhong Hu, Yuping Sun, Kunyu Yang, Mingwei Chen, Yan Yu, Jianming Ying, Ruiqi Huang, Xiaopeng Ma, Shiangjiin Leaw, Fan Bai, Zhirong Shen, Shangli Cai, Daming Gao, Jie Wang, Zhijie Wang

CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression

CUL4B-DDB1-COP1 介导的 UTX 下调促进结直肠癌进展

期刊:Experimental Hematology & Oncology

影响因子:9.4

doi:10.1186/s40164-023-00440-z

Dakui Luo #, Min Chen #, Qingguo Li #, Kangjunjie Wang, Kaihua Wang, Junqiang Li, Guoxiang Fu, Zezhi Shan, Qi Liu, Yufei Yang, Lei Liang, Yanlei Ma, Yi Qin, Jun Qin, Daming Gao, Xinxiang Li

Identification of XAF1 as an endogenous AKT inhibitor

鉴定 XAF1 为内源性 AKT 抑制剂

期刊:Cell Reports

影响因子:7.5

doi:10.1016/j.celrep.2023.112690

Min Chen, Kangjunjie Wang, Ying Han, Shukun Yan, Huairui Yuan, Qiuli Liu, Long Li, Ni Li, Hongwen Zhu, Dayun Lu, Kaihua Wang, Fen Liu, Dakui Luo, Yuxue Zhang, Jun Jiang, Dali Li, Lei Zhang, Hongbin Ji, Hu Zhou, Yong Chen, Jun Qin, Daming Gao

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities

对肝内胆管癌免疫亚群的多模块表征揭示了其独特的治疗脆弱性。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2022-004892

Lin, Jian; Dai, Yuting; Sang, Chen; Song, Guohe; Xiang, Bin; Zhang, Mao; Dong, Liangqing; Xia, Xiaoli; Ma, Jiaqiang; Shen, Xia; Ji, Shuyi; Zhang, Shu; Wang, Mingjie; Fang, Hai; Zhang, Xiaoming; Wang, Xiangdong; Zhang, Bing; Zhou, Jian; Fan, Jia; Zhou, Hu; Gao, Daming; Gao, Qiang

Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV

对 HBV（乙型肝炎病毒）-宿主相互作用的多组学研究揭示了人类基因组中新的编码潜力，并确定了典型和非典型蛋白质作为针对 HBV 的宿主限制因子

期刊:Cell Discovery

影响因子:13

doi:10.1038/s41421-021-00337-3

Shilin Yuan #, Guanghong Liao #, Menghuan Zhang #, Yuanfei Zhu #, Weidi Xiao #, Kun Wang, Chuanyin Li, Caiwei Jia, Na Sun, Axel Walch, Daming Gao, Ping Xu, Qiang Deng, Jian Zhang, He Wang, Ronggui Hu

Large-scale complementary carbon nanotube integrated circuits for harsh radiation environments

用于恶劣辐射环境的大规模互补碳纳米管集成电路

Pan-cancer proteogenomics expands the landscape of therapeutic targets

泛癌症蛋白质组学拓展了治疗靶点的范围

An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma

IL1RN 剪接产生的炎症检查点为 KRAS 突变型肝内胆管癌提供了治疗机会

Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma

基因组规模的 CRISPR 筛选确定了肝细胞癌中驱动仑伐替尼耐药性的 LAPTM5

CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs

CircRNF10通过重新激活GSC中的铁死亡防御机制，触发正反馈回路，促进胶质母细胞瘤的进展。

Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

肿瘤免疫微环境及NRF2与肺鳞状细胞癌PD-1阻断联合化疗临床疗效的关系

CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression

CUL4B-DDB1-COP1 介导的 UTX 下调促进结直肠癌进展

Identification of XAF1 as an endogenous AKT inhibitor

鉴定 XAF1 为内源性 AKT 抑制剂

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities

对肝内胆管癌免疫亚群的多模块表征揭示了其独特的治疗脆弱性。

Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV

对 HBV（乙型肝炎病毒）-宿主相互作用的多组学研究揭示了人类基因组中新的编码潜力，并确定了典型和非典型蛋白质作为针对 HBV 的宿主限制因子